NTH1 Antibodies

Santa Cruz Biotechnology provides a broad selection of NTH1 monoclonal antibodies for research focused on understanding DNA repair mechanisms. NTH1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NTH1, or endonuclease III, functions as a key enzyme in the base excision repair pathway, maintaining genomic stability through the repair of oxidative DNA damage. The role of NTH1 is essential for cellular responses to oxidative stress and helps prevent mutations that can lead to various diseases, including cancer. Research involving NTH1 continues to reveal new insights about DNA repair processes and their impact on cellular health. Understanding NTH1 mechanisms can lead to breakthrough therapeutic strategies for diseases associated with DNA damage. Ongoing studies of NTH1 highlight its significance in maintaining cellular integrity and preventing disease progression. Research utilizing NTH1 monoclonal antibodies from Santa Cruz Biotechnology enables scientists to advance understanding of DNA repair pathways and contribute to potential therapeutic developments.